SMAD4 is a pivotal signal transducer in the canonical Transforming Growth Factor-β (TGF-β) pathway, which forms a heterotrimeric complex with SMAD2/3 and translocates to the nucleus to suppress tumor progression [25]. The gene discussed is TGFB1; the disease is neoplasm.